Conor J Macevilly from 8021 28Th Ave NW, Seattle, WA 98117, age 61

Us Patents

Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
view source
US Patent:

7186691, Mar 6, 2007
Filed:

Dec 23, 2003
Appl. No.:

10/745069
Inventors:

Steven C. Quay - Edmonds WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Assignee:

Nastech Pharmaceutical Company Inc. - Rothell WA
International Classification:

A61K 38/17
A61K 38/28
C07K 14/435
US Classification:

514 12, 530324, 530303
Abstract:

Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.

Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
view source
US Patent:

7229966, Jun 12, 2007
Filed:

Feb 17, 2004
Appl. No.:

10/780325
Inventors:

Steven C. Quay - Edmonds WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Assignee:

Nastech Pharmaceutical Company Inc. - Bothell WA
International Classification:

A61K 38/17
A61K 38/28
C07K 14/435
B05B 11/02
US Classification:

514 12, 530324, 530303, 222631
Abstract:

Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.

Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
view source
US Patent:

20040209807, Oct 21, 2004
Filed:

Jan 30, 2004
Appl. No.:

10/768288
Inventors:

Steven Quay - Edmonds WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Kingston WA, US
Conor MacEvilly - Seattle WA, US
Assignee:

Nastech Pharmaceutical Company Inc.
International Classification:

A61K038/22
A61K031/70
A61K031/7012
A61K031/724
A61K031/045
US Classification:

514/012000, 514/023000, 514/053000, 514/058000, 514/738000
Abstract:

Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.

Methods For Determining The Amount Of Peptide Yy In Blood
view source
US Patent:

20050181456, Aug 18, 2005
Filed:

Feb 9, 2005
Appl. No.:

11/054245
Inventors:

Charles Foerder - Seattle WA, US
Conor MacEvilly - Seattle WA, US
International Classification:

G01N033/53
US Classification:

435007100
Abstract:

A method for determining the total amount of a Y2 receptor-binding such as PYY in a blood sample. Bound PYY is first freed from components in the blood and proteinaceous material in the blood precipitated preferably by the addition of an organic solvent miscible in water such as ethanol. The PYY remains in solution in a supernatant liquid. The supernatant liquid containing the PYY is removed and the total amount of PYY contained therein is determined preferably by means of an radioimmunoassay.

Compositions And Methods For Enhanced Mucosal Delivery Of Pyy Peptide
view source
US Patent:

20070129299, Jun 7, 2007
Filed:

Aug 25, 2006
Appl. No.:

11/467509
Inventors:

Steven Quay - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
International Classification:

A61K 38/22
A61K 31/724
US Classification:

514012000, 514058000
Abstract:

Pharmaceutical compositions are described comprising PYY(3-36) (SEQ ID NO: 2), a solubilizing agent, a lipid, a polyol.

A Device For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides
view source
US Patent:

20070161563, Jul 12, 2007
Filed:

Nov 22, 2006
Appl. No.:

11/562913
Inventors:

Steven Quay - Woodinville WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
International Classification:

A61K 38/22
A61K 31/70
A61K 31/7012
A61K 31/715
A61K 31/045
A61K 31/724
US Classification:

514012000, 514054000, 514058000, 514023000, 514061000, 514053000, 604500000, 514738000
Abstract:

A pharmaceutical device comprising a composition comprising an aqueous solution of PYY(3-36), a cyclodextrin, and a compound selected from phosphatidylcholine or diglyceride, wherein the cyclodextrin and the compound selected from phosphatidylcholine or diglyceride are present in an amount sufficient to enhance epithelial permeation, and wherein the composition is present in a container; and an actuator fluidly connected to the container, wherein the actuator has a tip which defines a passage through which the solution is ejected to produce a spray of the solution.

Compositions For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides
view source
US Patent:

20070197437, Aug 23, 2007
Filed:

Nov 20, 2006
Appl. No.:

11/561825
Inventors:

Steven Quay - Woodinville WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
International Classification:

A61K 38/22
A61K 31/724
US Classification:

514012000, 514058000
Abstract:

Pharmaceutical compositions comprising a PYY peptide, a cyclodextrin, and a compound selected from phosphatidylcholine or diglyceride, wherein the cyclodextrin and the compound selected from phosphatidylcholine or diglyceride are present in an amount sufficient to enhance epithelial permeation.

Conor Macevilly, Seattle WA Seattle Realtor

view source

Specialties:

Buyer's Agent
Listing Agent

Work:

Coldwell Banker Danforth, Northgate
2111 N. Northgate Way, Seattle, WA 98133
206 349-8477 (Office), 206 349-8477 (Cell)

Experience:

6 years

Description:

Hi there I'm a Realtor, real estate educator and a real estate therapist of varying proportions depending the particular client I'm working with and the particular stage of the purchase or sale we are in. I focus on Seattle neighborhoods north of downtown including Ballard, Magnolia, Queen Anne..basically all neighborhoods north of the Ship Canal but have also worked with buyers and sellers on the East Side, South Seattle and as far north as Mill Creek. I work with both Seattle home buyers and sellers. My real estate philosophy is that I'd be lying if I said buying or selling a home wasn't a wee bit stressful but it should also be fun experience. In my previous life I was a research biochemist / chemist. Failed to cure all major and minor diseases, so I decided to become a Realtor instead. Please contact me with any real estate related questions that you may have. Thanks for reading! Conor

Links:

Site
Blog
Facebook
Twitter
LinkedIn

Conor Macevilly, Seattle WA Agent

view source

Work:

Coldwell Banker Danforth, Northgate Office
Seattle, WA
206 349-8477 (Phone)

Seattle Realtor

view source

Location:

Seattle, WA

Industry:

Real Estate

Work:

Keller Williams Realty Greater Seattle
Seattle Realtor
Re/Max on Market Dec 2017 - Jul 2019
Seattle Realtor
Coldwell Banker Danforth May 2008 - Dec 2017
Realtor
Nastech Pharmaceutical Jan 2003 - Apr 2008
Senior Manager, Analytical Services
Oxis International 1999 - 2001
Manager

Education:

University of London 1987 - 1992
Doctorates, Doctor of Philosophy, Biochemistry School of Food and Nutritional Sciences 1982 - 1986
Bachelors, Bachelor of Science, Biochemistry

Skills:

Real Estate
Sellers
Real Estate Transactions
Relocation
Foreclosures
Investment Properties
Due Diligence
First Time Home Buyers
Short Sales
Property
Contract Negotiation
Negotiation
Real Property
Pharmaceutical Industry
Brokerage
Investors
Real Estate Development
Resellers
Selling
Luxury
Referrals
Licensing
Move Up Buyers
Residential Homes
Townhomes
Real Estate Economics
Strategy
Budgets
Property Management
Sales
Reo
Small Business
Buyer Representation
Listings
New Home Sales
Commercial Real Estate
Relocation Buyers
Fha
Condos
Leases
Abr
Biotechnology
Rentals
Buyers
Single Family Homes
Mortgage Lending
Seller Representation
Hud
Investments
New Homes